COVID-19 vaccines and their excipients
| Vaccine | Type of vaccine | Excipients |
|---|---|---|
| Pfizer-BioNtech BNT162b2 (Comirnaty) | mRNA | PEG 2000, DSPC |
| AstraZeneca AZD1222 (Vaxzevria) | Non-replicating chimpanzee Ad | PS80, EDTA |
| Moderna mRNA-1273 | mRNA | PEG 2000, DSPC |
| Johnson & Johnson COVID-19 vaccine (JNJ-78436725) | Recombinant, replication-incompetent, Ad-based vaccine | PS80 |
| Gam-COVID-Vac (Sputnik V) | Recombinant, replication-incompetent, Ad-based vaccine | PS80, EDTA |
| Novavax NVX-CoV2373 (Nuvaxovid) | Protein based vaccine | PS80 |
| SinoVac Biotech COVID-19 vaccine (CoronaVac) | Inactivated vaccine | - |
-: No excipients
Note. Adapted with permission from “Allergies and COVID-19 vaccines: an ENDA/EAACI position paper,” by Barbaud A, Garvey LH, Arcolaci A, Brockow K, Mori F, Mayorga C, et al. Allergy. 2022;77:2292–312 (https://onlinelibrary.wiley.com/doi/10.1111/all.15241). © 2022 EAACI and John Wiley and Sons A/S.